Article

Immunotherapy Time of Infusion Impacts Survival in Head and Neck Cancer: A Propensity Score Matched Analysis

2024-01-09

Abstract excerpt

The adaptive immune response is physiologically regulated by the circadian rhythm. Data in lung and melanoma malignancies suggests immunotherapy infusions earlier in the day may be associated with improved response; however, the optimal time of administration for patients with HNSCC is not known. We aimed to evaluate the association of immunotherapy infusion time with overall survival (OS) and progression free sur...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9cd7b90a-f0f7-5864-b433-6b6021e99ff1
DOI: 10.1101/2024.01.08.24300992

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy Time of Infusion Impacts Survival in Head and Neck Cancer: A Propensity Score Matched AnalysisDOI 10.1101/2024.01.08.24300992Read

Epigenetic modulation of immunotherapy and implications in head and neck cancerSemantic proximity Read

A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCCSemantic proximity Read

Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal studySemantic proximity Read

A Drug-Specific, Half-Life-Adjusted Framework for Classifying CNS-Active Systemic Therapy Exposure During and After RadiotherapySemantic proximity Read

Combination of immunotherapy and anti-EGFR agents in immunotherapy refractory head neck cancer recurrent and metastatic head neck squamous cell carcinomaSemantic proximity Read

First Measurement: Proactive Immune Cell Sparing in Radiation TherapySemantic proximity Read

Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck CancerSemantic proximity Read

Six-month mortality has decreased for patients with curative treatment for head and neck cancer in SwedenSemantic proximity Read

How do delays in treatment affect patient prognosis in head and neck cancer?Semantic proximity Read

Adjuvant pembrolizumab after upfront multimodal therapy for stage IVB Anaplastic Thyroid CancerSemantic proximity Read

Timing of Radiotherapy in Uveal Melanoma: A SEER-Based Comparison of Preoperative, Postoperative, and Intraoperative ApproachesSemantic proximity Read

Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort studySemantic proximity Read